NCT02733497

Brief Summary

Essential palmar hyperhidrosis (EPH) is a pathological condition of excessive sweating of the hands due to an unexplained over-activity of the T2 and T3 sympathetic fibers. Endoscopy Thoracoscopic Sympathectomy (ETS) is the treatment of choice in patients with EPH refractory to medical treatment . The cardiac sympathetic activity is mainly controlled by cervical sympathetic fibers but anatomic studies have showed that "accessory" fibers from the T2 and T3 sympathetic ganglia come to the heart and influence its function. Heart Rate Variability (HRV) is a simple and non-invasive method based on electrocardiogram to evaluate the sympathovagal balance at the sino-atrial level. Several studies have found that ETS caused a decrease of heart rate (HR), an increase of HR variability (HRV) and a shift of sympathovagal balance toward parasympathetic tone but remains unclear if these changes are associated with the extend of ETS. Thus, in the present study the investigator performed a prospective analysis of HRV function in patients with EPH undergoing different sympathetic denervations as sympathectomy and sympathicotomy with the hypothesis that cardiac autonomic changes could be associated with the extend of sympathetic resection.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2012

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2014

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

April 5, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 11, 2016

Completed
Last Updated

April 12, 2016

Status Verified

April 1, 2016

Enrollment Period

2.7 years

First QC Date

April 5, 2016

Last Update Submit

April 9, 2016

Conditions

Keywords

sympathectomy, sympathicotomy, heart rate variability,

Outcome Measures

Primary Outcomes (1)

  • Heart Rate (HR) measured in beats/min

    7 days, 1, 3 and 6 months after operation

Secondary Outcomes (2)

  • Post-operative complications

    Post-operative time and 7 days, 1, 3 and 6 months after operation

  • Compensatory hyperhidrosis measured with a scale ranging from 0 (absent) to 3 (severe)

    1, 3 and 6 months after operation

Study Arms (2)

Sympathectomy Group

ACTIVE COMPARATOR

Excision of ganglia at T3 level

Procedure: Sympathectomy

Sympathicotomy Group

ACTIVE COMPARATOR

Resection of sympathetic chain at T3 level

Procedure: Sympathicotomy

Interventions

SympathectomyPROCEDURE

Resection of ganglia at T3 level

Sympathectomy Group

Cutting of symptahetic chain at T3 level without ganglia excision

Sympathicotomy Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age more than 18 years
  • Severe hyperhidrosis

You may not qualify if:

  • Contraindications for general anaesthetic procedure and/or for selective endotracheal intubation
  • Previous pleural or lung diseases that make difficult the access to pleural cavityù
  • Cardiac diseases and/or taking medications with cardiac effects
  • Secondary hyperhidrosis including hyperthyroidism, acute and chronic infections, malignancy, and immunologic disorder
  • Mild or moderate palmar hyperhidrosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Katara AN, Domino JP, Cheah WK, So JB, Ning C, Lomanto D. Comparing T2 and T2-T3 ablation in thoracoscopic sympathectomy for palmar hyperhidrosis: a randomized control trial. Surg Endosc. 2007 Oct;21(10):1768-71. doi: 10.1007/s00464-007-9241-9. Epub 2007 Apr 3.

    PMID: 17404794BACKGROUND
  • Tedoriya T, Sakagami S, Ueyama T, Thompson L, Hetzer R. Influences of bilateral endoscopic transthoracic sympathicotomy on cardiac autonomic nervous activity. Eur J Cardiothorac Surg. 1999 Feb;15(2):194-8. doi: 10.1016/s1010-7940(98)00309-1.

    PMID: 10219553BACKGROUND
  • Cruz J, Sousa J, Oliveira AG, Silva-Carvalho L. Effects of endoscopic thoracic sympathectomy for primary hyperhidrosis on cardiac autonomic nervous activity. J Thorac Cardiovasc Surg. 2009 Mar;137(3):664-9. doi: 10.1016/j.jtcvs.2008.07.021. Epub 2008 Sep 24.

    PMID: 19258086BACKGROUND
  • Fiorelli A, Messina G, Chiodini P, Costanzo S, Viggiano A, Monda M, Vicidomini G, Santini M. Cardiac Autonomic Changes After Thoracic Sympathectomy: A Prospective, Randomized Study. Ann Thorac Surg. 2017 Jan;103(1):216-224. doi: 10.1016/j.athoracsur.2016.10.055. Epub 2016 Nov 23.

MeSH Terms

Conditions

Hyperhidrosis

Interventions

Sympathectomy

Condition Hierarchy (Ancestors)

Sweat Gland DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Autonomic DenervationDenervationNeurosurgical ProceduresSurgical Procedures, Operative

Study Officials

  • Mario Santini, MD

    University of Campania Luigi Vanvitelli

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

April 5, 2016

First Posted

April 11, 2016

Study Start

January 1, 2012

Primary Completion

September 1, 2014

Study Completion

October 1, 2014

Last Updated

April 12, 2016

Record last verified: 2016-04

Data Sharing

IPD Sharing
Will not share